FDA — authorised 21 May 1971
- Application: NDA050429
- Marketing authorisation holder: OXFORD PHARMS
- Local brand name: RIMACTANE
- Indication: CAPSULE — ORAL
- Status: approved
🇺🇸 Rimactane in United States
FDA authorised Rimactane on 21 May 1971
Marketing authorisation
Other Other approved in United States
Frequently asked questions
Is Rimactane approved in United States?
Yes. FDA authorised it on 21 May 1971.
Who is the marketing authorisation holder for Rimactane in United States?
OXFORD PHARMS holds the US marketing authorisation.